Ładuje się......
CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
SIMPLE SUMMARY: Dipeptidyl peptidase (DPP)-4 inhibitor is widely used for type 2 diabetes. Although DPP-4/CD26 has been recognized as both a suppressor and inducer in tumor biology due to its various functions, how DPP-4 inhibitor affects cancer progression in diabetic patients is still unknown. The...
Zapisane w:
| Wydane w: | Cancers (Basel) |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8124456/ https://ncbi.nlm.nih.gov/pubmed/34063285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092191 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|